Home
Search
BIO Clinical Trial Diversity Summit   |   November 19, 2024

Speakers & Presenters

All Speakers
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Ted Love, MD
CHAIR, BIO BOARD OF DIRECTORS
Welcome and Opening Remarks
Scout MA, PhD
EXECUTIVE DIRECTOR, NATIONAL LGBTQI+ CANCER NETWORK
Community Engagement: Building Lasting Relationships
Siham Mahgoub, MD
ASSOCIATE PROFESSOR OF MEDICINE, HOWARD UNIVERSITY COLLEGE OF MEDICINE
Increasing Access through Intentional Trial Designs
Jewell Martin, MA, MBA
DIRECTOR, US R&D AND REGULATORY POLICY, BIOMARIN PHARMACEUTICAL, INC.
Increasing Access through Intentional Trial Designs
Martin Mendoza, PhD
CHIEF HEALTH EQUITY OFFICER AND DIRECTOR OF THE OFFICE OF MINORITY HEALTH, CENTERS FOR MEDICARE AND MEDICAID SERVICES
Keynote Address
Elizabeth Ofili, MD, MPH, FACC
PROFESSOR OF MEDICINE, MOREHOUSE SCHOOL OF MEDICINE
Community Engagement: Building Lasting Relationships
Rosamund Round
VICE PRESIDENT OF PATIENT ENGAGEMENT, PRECISION FOR MEDICINE
Increasing Access through Intentional Trial Designs
Wendy Selig, MSJ
FOUNDER & CEO, WSCOLLABORATIVE
Increasing Access through Intentional Trial Designs
Carolyn Shore, PhD
DIRECTOR, FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION, NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Diversity Convergence Project
Shardae Showell, PhD
MEDICAL DIRECTOR, CLINICAL DEVELOPMENT, ALZHEIMER’S & DEMENTIA UNIT, BIOGEN
Increasing Access through Intentional Trial Designs